HLACRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。HLA遺伝子サイレンサーは、HLA CRISPR/Cas9ノックアウトプラスミドとHLADouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のHLACRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
CRISPR製品をまとめて購入するとさらにお得に！最大70％オフ！
HLA CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
HLA-A CRISPR/Cas9 KOプラスミド (h) | sc-400294 | h | Gene Knockout | GFP | 0 | ||
HLA-A HDRプラスミド (h) | sc-400294-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-A Double Nickaseプラスミド (h) | sc-400294-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-A Double Nickaseプラスミド (h2) | sc-400294-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-B CRISPR/Cas9 KOプラスミド (h) | sc-400627 | h | Gene Knockout | GFP | 0 | ||
HLA-B HDRプラスミド (h) | sc-400627-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-B Double Nickaseプラスミド (h) | sc-400627-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-B Double Nickaseプラスミド (h2) | sc-400627-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-C CRISPR/Cas9 KOプラスミド (h) | sc-401517 | h | Gene Knockout | GFP | 0 | ||
HLA-C HDRプラスミド (h) | sc-401517-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-C Double Nickaseプラスミド (h) | sc-401517-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-C Double Nickaseプラスミド (h2) | sc-401517-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMα Double Nickaseプラスミド (h) | sc-404576-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMα Double Nickaseプラスミド (h2) | sc-404576-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ CRISPR/Cas9 KOプラスミド (h) | sc-406436 | h | Gene Knockout | GFP | 0 | ||
HLA-DOβ CRISPR/Cas9 KOプラスミド (h) | sc-406402 | h | Gene Knockout | GFP | 0 | ||
HLA-DOβ CRISPR/Cas9 KOプラスミド (m) | sc-420773 | m | Gene Knockout | GFP | 0 | ||
HLA-DRα CRISPR/Cas9 KOプラスミド (h2) | sc-401010-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-DRα HDRプラスミド (h2) | sc-401010-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DRα Double Nickaseプラスミド (h) | sc-401010-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRα Double Nickaseプラスミド (h2) | sc-401010-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-E CRISPR/Cas9 KOプラスミド (h2) | sc-403124-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-E HDRプラスミド (h2) | sc-403124-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-E Double Nickaseプラスミド (h) | sc-403124-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-E Double Nickaseプラスミド (h2) | sc-403124-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-F CRISPR/Cas9 KOプラスミド (h) | sc-410821 | h | Gene Knockout | GFP | 0 | ||
HLA-F Double Nickaseプラスミド (h) | sc-410821-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-F Double Nickaseプラスミド (h2) | sc-410821-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-G CRISPR/Cas9 KOプラスミド (h2) | sc-401226-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-G HDRプラスミド (h2) | sc-401226-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-G Double Nickaseプラスミド (h) | sc-401226-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-G Double Nickaseプラスミド (h2) | sc-401226-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DP β1 CRISPR/Cas9 KOプラスミド (h) | sc-401413 | h | Gene Knockout | GFP | 0 | ||
HLA-DP β1 HDRプラスミド (h) | sc-401413-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DP β1 Double Nickaseプラスミド (h) | sc-401413-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DP β1 Double Nickaseプラスミド (h2) | sc-401413-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQA1 CRISPR/Cas9 KOプラスミド (h) | sc-403480 | h | Gene Knockout | GFP | 0 | ||
HLA-DQA1 HDRプラスミド (h) | sc-403480-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DQA1 Double Nickaseプラスミド (h) | sc-403480-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQA1 Double Nickaseプラスミド (h2) | sc-403480-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB1 CRISPR/Cas9 KOプラスミド (h2) | sc-403051-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-DQB1 Double Nickaseプラスミド (h) | sc-403051-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB1 Double Nickaseプラスミド (h2) | sc-403051-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ1 CRISPR/Cas9 KOプラスミド (h) | sc-406727 | h | Gene Knockout | GFP | 0 | ||
HLA-DRβ1 Double Nickaseプラスミド (h) | sc-406727-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ1 Double Nickaseプラスミド (h2) | sc-406727-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ5 Double Nickaseプラスミド (h) | sc-402985-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ5 Double Nickaseプラスミド (h2) | sc-402985-NIC-2 | h | Gene Knockout | Puromycin | 0 |
HLA CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
HLA-A CRISPR Activationプラスミド (h) | sc-400294-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-A Lentiviral Activation Particles (h) | sc-400294-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-B CRISPR Activationプラスミド (h) | sc-400627-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-C CRISPR Activationプラスミド (h) | sc-401517-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRα CRISPR Activationプラスミド (h) | sc-401010-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRα CRISPR Activationプラスミド (h2) | sc-401010-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E CRISPR Activationプラスミド (h) | sc-403124-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E Lentiviral Activation Particles (h) | sc-403124-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E CRISPR Activationプラスミド (m) | sc-437133-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E CRISPR Activationプラスミド (m2) | sc-437133-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E Lentiviral Activation Particles (m) | sc-437133-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-F CRISPR Activationプラスミド (h) | sc-410821-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-G CRISPR Activationプラスミド (h) | sc-401226-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DP β1 CRISPR Activationプラスミド (h) | sc-401413-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DP β1 CRISPR Activationプラスミド (h2) | sc-401413-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQA1 CRISPR Activationプラスミド (h) | sc-403480-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQB1 CRISPR Activationプラスミド (h) | sc-403051-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ1 CRISPR Activationプラスミド (h) | sc-406727-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ1 CRISPR Activationプラスミド (h2) | sc-406727-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ5 CRISPR Activationプラスミド (h) | sc-402985-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 |